000 04134nam a22005655i 4500
001 978-3-031-63366-9
003 DE-He213
005 20251030113039.0
007 cr nn 008mamaa
008 240820s2024 sz | s |||| 0|eng d
020 _a9783031633669
_9978-3-031-63366-9
024 7 _a10.1007/978-3-031-63366-9
_2doi
050 4 _aRC633-647
072 7 _aMJF
_2bicssc
072 7 _aMED038000
_2bisacsh
072 7 _aMJF
_2thema
245 1 0 _aAcute Myeloid Leukemia in Children
_h[electronic resource] :
_bStandard of Care and Future Perspectives /
_cedited by Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aVIII, 342 p. 41 illus., 39 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aPediatric Oncology,
_x2191-0812
505 0 _a Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML -- Chromosomal and Genomic Alterations in Pediatric AML -- Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML -- Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML -- Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma) -- Acute Promyelocytic Leukemia -- Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM) -- Myeloproliferative Disorders in Non-Down Syndrome Patients -- AML in Specific Age Groups (Infants. Adolescents and Young Adults) -- Myeloid Neoplasms Post Cytotoxic Therapy in Children -- Advanced MDS in Children -- Relapsed/Refractory AML in Children and Evolution of Novel Therapies -- Stem Cell Transplantation/Cellular and Immunotherapies -- Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML -- Cardiotoxicity in Pediatric AML -- Late effects in Pediatric AML Survivors.
520 _aThis book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.
650 0 _aHematology.
_976927
650 0 _aOncology.
_970760
650 0 _aPediatrics.
_964087
650 1 4 _aHematology.
_976927
650 2 4 _aOncology.
_970760
650 2 4 _aPediatrics.
_964087
700 1 _aTomizawa, Daisuke.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_984187
700 1 _aKolb, Edward Anders.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_984188
700 1 _aReinhardt, Dirk.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_984189
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031633652
776 0 8 _iPrinted edition:
_z9783031633676
776 0 8 _iPrinted edition:
_z9783031633683
830 0 _aPediatric Oncology,
_x2191-0812
_977125
856 4 0 _uhttps://doi.org/10.1007/978-3-031-63366-9
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c63329
_d63329